Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicinal composition containing Esopiclone and preparation method thereof

A technology for eszopiclone and composition, which is applied in the field of pharmaceutical compositions containing eszopiclone, and can solve the problems of poor content uniformity, low dissolution rate and the like

Active Publication Date: 2011-11-09
CHENGDU KANGHONG PHARMA GRP
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] One of the technical problems to be solved in the present invention is to solve the problems of poor content uniformity and low dissolution rate of the existing eszopiclone pharmaceutical composition

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition containing Esopiclone and preparation method thereof
  • Medicinal composition containing Esopiclone and preparation method thereof
  • Medicinal composition containing Esopiclone and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1 to 8

[0135] Embodiment 1 to 8, see table 17: (by weight)

[0136] Table 17 Examples 1 to 8

[0137]

[0138] The preparation method of above embodiment:

[0139] It adopts wet granulation, compresses tablets or packs capsules, and the preparation process is as follows:

[0140] (1) Take eszopiclone (with a particle size range of 50 μm-165 μm) and dextrin and mix them uniformly;

[0141] (2) Combine the sieved hydroxypropyl cellulose with disintegrating agent, starch, lactose, and microcrystalline cellulose, sieve, and mix evenly to obtain an auxiliary material mixture.

[0142] (3) Take the homogeneously mixed mixture of eszopiclone and dextrin, mix it uniformly with the mixture of auxiliary materials in an equal amount incremental method, add an appropriate amount of 10% povidone K30 solution to make a soft material, granulate, dry at 60°C, and granulate;

[0143] (4) Add micropowder silica gel and magnesium stearate, mix well, measure the content of the main drug in the gra...

Embodiment 9 to 15

[0155] Embodiment 9 to 15, see table 20: (by weight)

[0156] Table 20 Examples 9 to 15

[0157]

[0158] The preparation method of above embodiment:

[0159] It adopts wet granulation, compresses tablets or packs capsules, and the preparation process is as follows:

[0160] (1) Take eszopiclone (with a particle size range of 50 μm-125 μm) and dextrin and mix them uniformly;

[0161] (2) Combine the sieved hydroxypropyl cellulose with disintegrating agent, starch, lactose, and microcrystalline cellulose, sieve, and mix evenly to obtain an auxiliary material mixture.

[0162] (3) Take the homogeneously mixed mixture of eszopiclone and dextrin, mix it uniformly with the mixture of auxiliary materials in an equal amount incremental method, add an appropriate amount of 10% povidone K30 solution to make a soft material, granulate, dry at 60°C, and granulate;

[0163] (4) Add micropowder silica gel and magnesium stearate, mix well, measure the content of the main drug in the g...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a medicinal composition containing Esopiclone and a preparation method thereof. The Esopiclone-containing medicinal composition consists of a main medicine and auxiliary materials. In the invention, by controlling the particle size of the main medicine, a pre-mixing method and the auxiliary materials, the medicinal composition which has high dissolution rate and high content uniformity can be obtained. The preparation method adopts a modern preparation technique, the quality of the product is stable, and an Esopiclone-containing solid oral preparation which is safe, effective, quick in absorption, high in bioavailability and accurate in dosage is provided for patients.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a pharmaceutical composition containing eszopiclone. Background technique [0002] Insomnia is one of the most common clinical symptoms, and the incidence rate is very high. According to the survey results in the United States, in the past 20 years, the prevalence rate of insomnia was about 30% to 35%, and 10% to 15% of patients with insomnia The degree is quite serious, and the findings in the UK and Australia are similar. In China, a sample survey by the Chinese Medical Association shows that the incidence of insomnia in the population rose to more than 40% in 2003, and the number of insomnia is still increasing and showing a rising trend. At present, about 300 million adults in China suffer from insomnia symptoms such as insomnia, difficulty falling asleep, not sleeping soundly, dreaming and waking up easily, waking up early and difficulty falling asleep. The resul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4985A61K47/40A61P25/20A61J3/07A61J3/10
Inventor 杨刚张启余
Owner CHENGDU KANGHONG PHARMA GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com